search
Back to results

The Effect of Low Intensity Shock Wave Therapy for ED in PDE5i Non Responders (LI-ESWT)

Primary Purpose

Erectile Dysfunction

Status
Completed
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
LI-ESWT
Sponsored by
Rambam Health Care Campus
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Erectile Dysfunction focused on measuring LI-ESWT, Erectile Dysfunction, Non PDE5 inhibitor responders, Shock wave

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • ED of more than 6 months
  • Rigidity score ≤ 2 during PDE5i therapy
  • Stable heterosexual relationship for more than 3 months
  • Patients need to know and to agree that the study protocol does not allow any PDE5I therapy till week 13 .

Exclusion Criteria:

  • Prior surgery or radiotherapy in pelvic region
  • Any unstable, psychiatric, spinal cord injury and penile anatomical abnormalities
  • Clinically significant chronic hematological disease
  • Anti-androgens, oral or injectable androgens
  • Cardiovascular conditions that prevent sexual activity

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    LI-ESWT

    Arm Description

    Low intensity shock wave treatment- 12 sessions

    Outcomes

    Primary Outcome Measures

    IIEF-ED Domain score
    Change of 5 points and above in IIEF-ED Domain score

    Secondary Outcome Measures

    rigidity scale
    a change to 3 or 4 points in the rigidty scale

    Full Information

    First Posted
    December 14, 2010
    Last Updated
    December 18, 2012
    Sponsor
    Rambam Health Care Campus
    Collaborators
    Medispec
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01272297
    Brief Title
    The Effect of Low Intensity Shock Wave Therapy for ED in PDE5i Non Responders
    Acronym
    LI-ESWT
    Official Title
    The Effect of Low Intensity Shock Wave Therapy in Severe ED Patients Not Responding to Oral Medication
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    December 2012
    Overall Recruitment Status
    Completed
    Study Start Date
    January 2010 (undefined)
    Primary Completion Date
    September 2010 (Actual)
    Study Completion Date
    October 2010 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Rambam Health Care Campus
    Collaborators
    Medispec

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Low Intensity Shock Wave Therapy (LI-ESWT) was shown to have a beneficial effect on ED patients responding to PDE5i's. This study aimed to determine the capability of swt to convert PDE5 inhibitor non responders to sexually functioning males under PDE5i therapy.
    Detailed Description
    We included severe ED patients (60% diabetic, 85% with cardiovascular disease) that failed to respond to PDE5i therapy, who scored 0-2 on the rigidity scale (RS) during PDE5i therapy.Treatment included 2 sessions/week for 3 weeks, repeated after a 3-week no-treatment interval. At each session LI-ESWT was applied on the penile shaft and crus for 3 minutes in 5 different penile anatomical sites (intensity of 0.09 mj/mm2, 300 shocks/site). One-month after end of treatment the same baseline assessment was repeated. An active PDE5i medication regime was then provided and final erectile function was reassessed. Main endpoints for success were changes in RS and in the International Index of Erectile Function (IIEF-ED) Domain score. We found that LI-ESWT can effectively treat severe ED patients who failed PDE5i therapy. This study further emphasises the physiological effect that LI-ESWT can have on the erectile mechanism.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Erectile Dysfunction
    Keywords
    LI-ESWT, Erectile Dysfunction, Non PDE5 inhibitor responders, Shock wave

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 3
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    29 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    LI-ESWT
    Arm Type
    Experimental
    Arm Description
    Low intensity shock wave treatment- 12 sessions
    Intervention Type
    Device
    Intervention Name(s)
    LI-ESWT
    Other Intervention Name(s)
    Omnispec model ED1000
    Intervention Description
    Low intensity shock wave treatment - 12 sessions
    Primary Outcome Measure Information:
    Title
    IIEF-ED Domain score
    Description
    Change of 5 points and above in IIEF-ED Domain score
    Time Frame
    17 weeks after first visit
    Secondary Outcome Measure Information:
    Title
    rigidity scale
    Description
    a change to 3 or 4 points in the rigidty scale
    Time Frame
    17 weeks from visit 1

    10. Eligibility

    Sex
    Male
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    80 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: ED of more than 6 months Rigidity score ≤ 2 during PDE5i therapy Stable heterosexual relationship for more than 3 months Patients need to know and to agree that the study protocol does not allow any PDE5I therapy till week 13 . Exclusion Criteria: Prior surgery or radiotherapy in pelvic region Any unstable, psychiatric, spinal cord injury and penile anatomical abnormalities Clinically significant chronic hematological disease Anti-androgens, oral or injectable androgens Cardiovascular conditions that prevent sexual activity
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Yoram Vardi, Prof
    Organizational Affiliation
    Rambam Health Care Campus
    Official's Role
    Principal Investigator
    First Name & Middle Initial & Last Name & Degree
    Ilan Gruenwald, MD
    Organizational Affiliation
    Rambam Health Care Campus
    Official's Role
    Study Director
    First Name & Middle Initial & Last Name & Degree
    Boaz Appel, MD
    Organizational Affiliation
    Rambam Health Care Campus
    Official's Role
    Study Director
    First Name & Middle Initial & Last Name & Degree
    Ezra Gerber, RN
    Organizational Affiliation
    Rambam Health Care Campus
    Official's Role
    Study Director
    First Name & Middle Initial & Last Name & Degree
    Yaron Ofer, MD
    Organizational Affiliation
    Rambam Health Care Campus
    Official's Role
    Study Director
    First Name & Middle Initial & Last Name & Degree
    Omar Massarwa, RN
    Organizational Affiliation
    Rambam Health Care Campus
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Learn more about this trial

    The Effect of Low Intensity Shock Wave Therapy for ED in PDE5i Non Responders

    We'll reach out to this number within 24 hrs